PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EW vs. SYK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


EWSYK
YTD Return12.72%13.42%
1Y Return-2.31%14.26%
3Y Return (Ann)-3.47%10.11%
5Y Return (Ann)8.03%13.96%
10Y Return (Ann)20.19%17.32%
Sharpe Ratio-0.030.71
Daily Std Dev28.38%20.79%
Max Drawdown-52.78%-58.63%
Current Drawdown-34.23%-5.53%

Fundamentals


EWSYK
Market Cap$52.02B$127.69B
EPS$2.30$8.26
PE Ratio37.5840.63
PEG Ratio5.192.92
Revenue (TTM)$6.14B$20.50B
Gross Profit (TTM)$4.30B$11.65B
EBITDA (TTM)$1.92B$5.25B

Correlation

-0.50.00.51.00.4

The correlation between EW and SYK is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

EW vs. SYK - Performance Comparison

In the year-to-date period, EW achieves a 12.72% return, which is significantly lower than SYK's 13.42% return. Over the past 10 years, EW has outperformed SYK with an annualized return of 20.19%, while SYK has yielded a comparatively lower 17.32% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


2,000.00%3,000.00%4,000.00%5,000.00%6,000.00%7,000.00%NovemberDecember2024FebruaryMarchApril
6,150.91%
2,478.02%
EW
SYK

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Edwards Lifesciences Corporation

Stryker Corporation

Risk-Adjusted Performance

EW vs. SYK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EW
Sharpe ratio
The chart of Sharpe ratio for EW, currently valued at -0.03, compared to the broader market-2.00-1.000.001.002.003.004.00-0.03
Sortino ratio
The chart of Sortino ratio for EW, currently valued at 0.16, compared to the broader market-4.00-2.000.002.004.006.000.16
Omega ratio
The chart of Omega ratio for EW, currently valued at 1.02, compared to the broader market0.501.001.501.02
Calmar ratio
The chart of Calmar ratio for EW, currently valued at -0.02, compared to the broader market0.002.004.006.00-0.02
Martin ratio
The chart of Martin ratio for EW, currently valued at -0.05, compared to the broader market0.0010.0020.0030.00-0.05
SYK
Sharpe ratio
The chart of Sharpe ratio for SYK, currently valued at 0.71, compared to the broader market-2.00-1.000.001.002.003.004.000.71
Sortino ratio
The chart of Sortino ratio for SYK, currently valued at 1.13, compared to the broader market-4.00-2.000.002.004.006.001.13
Omega ratio
The chart of Omega ratio for SYK, currently valued at 1.15, compared to the broader market0.501.001.501.15
Calmar ratio
The chart of Calmar ratio for SYK, currently valued at 0.89, compared to the broader market0.002.004.006.000.89
Martin ratio
The chart of Martin ratio for SYK, currently valued at 2.38, compared to the broader market0.0010.0020.0030.002.38

EW vs. SYK - Sharpe Ratio Comparison

The current EW Sharpe Ratio is -0.03, which is lower than the SYK Sharpe Ratio of 0.71. The chart below compares the 12-month rolling Sharpe Ratio of EW and SYK.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50NovemberDecember2024FebruaryMarchApril
-0.03
0.71
EW
SYK

Dividends

EW vs. SYK - Dividend Comparison

EW has not paid dividends to shareholders, while SYK's dividend yield for the trailing twelve months is around 0.91%.


TTM20232022202120202019201820172016201520142013
EW
Edwards Lifesciences Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SYK
Stryker Corporation
0.91%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%1.34%1.46%

Drawdowns

EW vs. SYK - Drawdown Comparison

The maximum EW drawdown since its inception was -52.78%, smaller than the maximum SYK drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for EW and SYK. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-34.23%
-5.53%
EW
SYK

Volatility

EW vs. SYK - Volatility Comparison

Edwards Lifesciences Corporation (EW) has a higher volatility of 5.70% compared to Stryker Corporation (SYK) at 4.79%. This indicates that EW's price experiences larger fluctuations and is considered to be riskier than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
5.70%
4.79%
EW
SYK

Financials

EW vs. SYK - Financials Comparison

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Stryker Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items